OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated ...

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast ...

SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...

Wacker Chemie AG (Munich, Germany)’s has combined expertise in GMP manufacturing of biologics, including pDNA, with Gearbox Bioscience’s innovative solutions for antibiotic-free plasmid proliferation ...

The NFL has replaced the traditional 10-yard chain measurement for first downs with a virtual system. The new system uses Sony's Hawk-Eye technology and six 8K cameras in each stadium to optically ...

Since 2001, the InfoWorld Technology of the Year Awards have celebrated the most groundbreaking products in information technology—the products that change how companies operate and how people work.

IMUNON announces promising Phase 1 results for IMNN-101, a DNA plasmid vaccine demonstrating enhanced durability and potential advantages over mRNA vaccines. Phase 1 clinical trial results of IMNN-101 ...

Today, the Council on Environmental Quality (CEQ), in consultation with the National Energy Dominance Council and relevant permitting agencies, issued a Permitting Technology Action Plan to modernize ...

BNSF has laid off part of its technology services staff as it restructures that department, the company confirmed in a prepared statement provided to the Fort Worth Star-Telegram. BNSF would not ...